In a dramatic demonstration of the transformative power of strategic mergers, Protagenic Therapeutics (PTIX) stock rocketed up by 240% following its merger with Phytanix, placing the company on an accelerated trajectory in the highly competitive biotech sector. This significant share price surge signals the market’s bullish response to this merger, which is seen as a […]